C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2588705
The present invention provides a method for determining the presence of prostate cancer in a subject which method comprises determining the level of expression of one or more markers in a blood sample from the subject, wherein said one or more markers comprise at least one of EM, c-met, pRB, EZH2, e-cad, CAXII, CAIX, HIF-1.alpha., Jagged, PIM- 1, hepsin, RECK, Clusterin, MMP9, MTSP- 1, MMP24, MMP15, IGFBP-2, IGFBP-3, E2F4, caveolin, EF-1A, Kallikrein 2, Kallikrein 3 and PSGR.
Cette invention concerne un procédé permettant de déterminer la présence d'un cancer de la prostate chez un sujet, lequel procédé consiste à déterminer le niveau d'expression d'un ou plusieurs marqueurs dans un échantillon sanguin prélevé sur le sujet, le ou les marqueurs comprenant au moins un des éléments suivants: E2F3, c-met, pRB, EZH2, e-cad, CAXII, CAIX, HIF-1.alpha., Jagged, PIM- 1, hepsine, RECK, Clusterine, MMP9, MTSP-1, MMP24, MMP15, IGFBP-2, IGFBP-3, E2F4, cavéoline, EF-1A, Kallikréine 2, Kallikréine 3 et PSGR.
Carter Nicholas David
Fenske Christiane Dorothea
Nair Sabarinath Balachandran
Pipinikas Christodoulos
Osler Hoskin & Harcourt Llp
St. George's Enterprises Limited
LandOfFree
Diagnosis of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of prostate cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1372586